CytomX Therapeutics (CTMX) Change in Receivables (2016 - 2025)
Historic Change in Receivables for CytomX Therapeutics (CTMX) over the last 12 years, with Q3 2025 value amounting to -$240000.0.
- CytomX Therapeutics' Change in Receivables fell 14159.45% to -$240000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 million, marking a year-over-year decrease of 28467.31%. This contributed to the annual value of -$329000.0 for FY2024, which is 9898.94% up from last year.
- Per CytomX Therapeutics' latest filing, its Change in Receivables stood at -$240000.0 for Q3 2025, which was down 14159.45% from -$87000.0 recorded in Q2 2025.
- CytomX Therapeutics' Change in Receivables' 5-year high stood at $34.2 million during Q4 2022, with a 5-year trough of -$34.9 million in Q1 2023.
- For the 5-year period, CytomX Therapeutics' Change in Receivables averaged around $43736.8, with its median value being $58000.0 (2022).
- In the last 5 years, CytomX Therapeutics' Change in Receivables soared by 3536804.12% in 2022 and then plummeted by 1514137.93% in 2023.
- Quarter analysis of 5 years shows CytomX Therapeutics' Change in Receivables stood at -$97000.0 in 2021, then soared by 35368.04% to $34.2 million in 2022, then crashed by 97.04% to $1.0 million in 2023, then plummeted by 124.58% to -$249000.0 in 2024, then grew by 3.61% to -$240000.0 in 2025.
- Its last three reported values are -$240000.0 in Q3 2025, -$87000.0 for Q2 2025, and -$1.1 million during Q1 2025.